Piribedil

DB12478

small molecule investigational

Deskripsi

Piribedil has been investigated in Parkinson's Disease.

Struktur Molekul 2D

Berat 298.346
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

101 Data
Cabergoline The risk or severity of adverse effects can be decreased when Cabergoline is combined with Piribedil.
Ropinirole The risk or severity of adverse effects can be decreased when Ropinirole is combined with Piribedil.
Dihydroergotamine The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Piribedil.
Pramipexole The risk or severity of adverse effects can be decreased when Pramipexole is combined with Piribedil.
Lisuride The risk or severity of adverse effects can be decreased when Lisuride is combined with Piribedil.
Apomorphine The risk or severity of adverse effects can be decreased when Apomorphine is combined with Piribedil.
Fenoldopam The risk or severity of adverse effects can be decreased when Fenoldopam is combined with Piribedil.
Ergoloid mesylate The risk or severity of adverse effects can be decreased when Ergoloid mesylate is combined with Piribedil.
Pergolide The risk or severity of adverse effects can be decreased when Pergolide is combined with Piribedil.
Bromocriptine The risk or severity of adverse effects can be decreased when Bromocriptine is combined with Piribedil.
Aripiprazole The risk or severity of adverse effects can be decreased when Aripiprazole is combined with Piribedil.
Rotigotine The risk or severity of adverse effects can be decreased when Rotigotine is combined with Piribedil.
Quinagolide The risk or severity of adverse effects can be decreased when Quinagolide is combined with Piribedil.
Brexpiprazole The risk or severity of adverse effects can be decreased when Brexpiprazole is combined with Piribedil.
Dihydroergocornine The risk or severity of adverse effects can be decreased when Dihydroergocornine is combined with Piribedil.
Dopexamine The risk or severity of adverse effects can be decreased when Dopexamine is combined with Piribedil.
Dihydrexidine The risk or severity of adverse effects can be decreased when Piribedil is combined with Dihydrexidine.
Dihydroergocryptine The risk or severity of adverse effects can be decreased when Piribedil is combined with Dihydroergocryptine.
Metergoline The risk or severity of adverse effects can be decreased when Piribedil is combined with Metergoline.
Methylphenidate The risk or severity of adverse effects can be increased when Methylphenidate is combined with Piribedil.
Dexmethylphenidate The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Piribedil.
Metoclopramide The therapeutic efficacy of Piribedil can be decreased when used in combination with Metoclopramide.
Olanzapine The therapeutic efficacy of Piribedil can be decreased when used in combination with Olanzapine.
Clozapine The therapeutic efficacy of Piribedil can be decreased when used in combination with Clozapine.
Risperidone The therapeutic efficacy of Piribedil can be decreased when used in combination with Risperidone.
Quetiapine The therapeutic efficacy of Piribedil can be decreased when used in combination with Quetiapine.
Paliperidone The therapeutic efficacy of Piribedil can be decreased when used in combination with Paliperidone.
Bifeprunox The therapeutic efficacy of Piribedil can be decreased when used in combination with Bifeprunox.
Iloperidone The therapeutic efficacy of Piribedil can be decreased when used in combination with Iloperidone.
Cariprazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Cariprazine.
Lumateperone The therapeutic efficacy of Piribedil can be decreased when used in combination with Lumateperone.
Sertindole The therapeutic efficacy of Piribedil can be decreased when used in combination with Sertindole.
Asenapine The therapeutic efficacy of Piribedil can be decreased when used in combination with Asenapine.
Lurasidone The therapeutic efficacy of Piribedil can be decreased when used in combination with Lurasidone.
Perospirone The therapeutic efficacy of Piribedil can be decreased when used in combination with Perospirone.
Blonanserin The therapeutic efficacy of Piribedil can be decreased when used in combination with Blonanserin.
Melperone The therapeutic efficacy of Piribedil can be decreased when used in combination with Melperone.
Zotepine The therapeutic efficacy of Piribedil can be decreased when used in combination with Zotepine.
Brilaroxazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Brilaroxazine.
Amisulpride The therapeutic efficacy of Piribedil can be decreased when used in combination with Amisulpride.
Loxapine The therapeutic efficacy of Piribedil can be decreased when used in combination with Loxapine.
Promazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Promazine.
Prochlorperazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Prochlorperazine.
Droperidol The therapeutic efficacy of Piribedil can be decreased when used in combination with Droperidol.
Chlorpromazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Chlorpromazine.
Fluphenazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Fluphenazine.
Thioridazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Thioridazine.
Trifluoperazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Trifluoperazine.
Perphenazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Perphenazine.
Mesoridazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Mesoridazine.
Pimozide The therapeutic efficacy of Piribedil can be decreased when used in combination with Pimozide.
Chlorprothixene The therapeutic efficacy of Piribedil can be decreased when used in combination with Chlorprothixene.
Methotrimeprazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Methotrimeprazine.
Periciazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Periciazine.
Molindone The therapeutic efficacy of Piribedil can be decreased when used in combination with Molindone.
Thioproperazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Thioproperazine.
Thiothixene The therapeutic efficacy of Piribedil can be decreased when used in combination with Thiothixene.
Zuclopenthixol The therapeutic efficacy of Piribedil can be decreased when used in combination with Zuclopenthixol.
Azaperone The therapeutic efficacy of Piribedil can be decreased when used in combination with Azaperone.
Bupropion The risk or severity of adverse effects can be increased when Bupropion is combined with Piribedil.
Methylergometrine The therapeutic efficacy of Piribedil can be decreased when used in combination with Methylergometrine.
Thiethylperazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Thiethylperazine.
Sulpiride The therapeutic efficacy of Piribedil can be decreased when used in combination with Sulpiride.
Remoxipride The therapeutic efficacy of Piribedil can be decreased when used in combination with Remoxipride.
Buspirone The therapeutic efficacy of Piribedil can be decreased when used in combination with Buspirone.
Triflupromazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Triflupromazine.
Amoxapine The therapeutic efficacy of Piribedil can be decreased when used in combination with Amoxapine.
Propiomazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Propiomazine.
Carphenazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Carphenazine.
Acetophenazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Acetophenazine.
Promethazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Promethazine.
Domperidone The therapeutic efficacy of Piribedil can be decreased when used in combination with Domperidone.
Yohimbine The therapeutic efficacy of Piribedil can be decreased when used in combination with Yohimbine.
Alizapride The therapeutic efficacy of Piribedil can be decreased when used in combination with Alizapride.
Acepromazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Acepromazine.
Aceprometazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Aceprometazine.
Pipotiazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Pipotiazine.
Fluspirilene The therapeutic efficacy of Piribedil can be decreased when used in combination with Fluspirilene.
YKP-1358 The therapeutic efficacy of Piribedil can be decreased when used in combination with YKP-1358.
Bromopride The therapeutic efficacy of Piribedil can be decreased when used in combination with Bromopride.
AS-8112 The therapeutic efficacy of Piribedil can be decreased when used in combination with AS-8112.
Pipamperone The therapeutic efficacy of Piribedil can be decreased when used in combination with Pipamperone.
Tetrahydropalmatine The therapeutic efficacy of Piribedil can be decreased when used in combination with Tetrahydropalmatine.
Ecopipam The therapeutic efficacy of Piribedil can be decreased when used in combination with Ecopipam.
Raclopride The therapeutic efficacy of Piribedil can be decreased when used in combination with Raclopride.
JNJ-37822681 The therapeutic efficacy of Piribedil can be decreased when used in combination with JNJ-37822681.
Perazine The therapeutic efficacy of Piribedil can be decreased when used in combination with Perazine.
Benperidol The therapeutic efficacy of Piribedil can be decreased when used in combination with Benperidol.
Tiapride The therapeutic efficacy of Piribedil can be decreased when used in combination with Tiapride.
Sultopride The therapeutic efficacy of Piribedil can be decreased when used in combination with Sultopride.
Clebopride The therapeutic efficacy of Piribedil can be decreased when used in combination with Clebopride.
Trifluperidol The therapeutic efficacy of Piribedil can be decreased when used in combination with Trifluperidol.
Penfluridol The therapeutic efficacy of Piribedil can be decreased when used in combination with Penfluridol.
Clopenthixol The therapeutic efficacy of Piribedil can be decreased when used in combination with Clopenthixol.
Fallypride The therapeutic efficacy of Piribedil can be decreased when used in combination with Fallypride.
Eticlopride The therapeutic efficacy of Piribedil can be decreased when used in combination with Eticlopride.
Ziprasidone The therapeutic efficacy of Piribedil can be decreased when used in combination with Ziprasidone.
Haloperidol The therapeutic efficacy of Piribedil can be decreased when used in combination with Haloperidol.
Flupentixol The therapeutic efficacy of Piribedil can be decreased when used in combination with Flupentixol.
Aripiprazole lauroxil The therapeutic efficacy of Piribedil can be decreased when used in combination with Aripiprazole lauroxil.

Target Protein

D(3) dopamine receptor DRD3
Alpha-2C adrenergic receptor ADRA2C
5-hydroxytryptamine receptor 1A HTR1A
D(4) dopamine receptor DRD4
5-hydroxytryptamine receptor 2B HTR2B
D(2) dopamine receptor DRD2

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul